What is the PARTNER 3 trial and what are the objectives?

The PARTNER 3 trial is a national study determining the safety and effectiveness of transcatheter aortic valve replacement (TAVR) using the Edwards SAPIEN 3 (3nd generation) device in the low risk for surgical aortic valve replacement (AVR) population.